2Meisser BM, Pfeiffer M, Jagiello-Kraatz M, et al. Mycophenolate mofetil dose adjustments based on trough levels improve outcome after heart transplantation significantly[J]. J Heart Lung Transplant,1998; 17(1):85-88.
3Sanquer S, Breil M, Baron C, et al. Trough blood concentrations in long-term treatment with mycophenolate mofeti[J]. Lancet,1998;351(9115):1557-1561.
4Jones CE, Taylor PJ, Johnson AG, et al. High-performance liquid chromatography determination of mycophenolic acid and its glucuronide metabolite in human plasma[J]. J Chromatogr B Biomed Sci Appl, 1998; 708(1): 229-233.
5Na-Bangchang K, Supasyndh O, Supaporn T, et al. Simple and sensitive high-performance liquid chromatographic method for the determination of mycophenolic acid in plasma[J]. J Chromatogr B Biomed Sci Appl, 2000;738(1): 169-173.
6Svensson J, Brattstrom C, Sawe J, et al. A simple HPLC method for simultaneous determination of mycophenolic acid and mycophenolic acid glucuronide in plasma[J]. Ther Drug Monit, 1999; 21(3): 322-324.
7H Jiang and M Kobayashi. Differences Between cyclosporine A and Tacrolimus in Organ Transplantation [J], Transplant Proc, 1999,31:1978
8Tanaka H,Kuroda A,Marusawa H,et al. Physicochemical properties of FK506, a novel immunosuppressant isolated from Streptomyces tsukubaensis[J]. Transplant proc, 1987, 19:11
9Brunet M, Pou L, Torra M. Comparative analysis of tacrolimus (FK506) in whole blood liver transplant recipients by PRO TRAC enzyme-linked immunosorbent assay and micropartical enzyme immunoassay IMX methods [J]. Ther Drug Monit, 1996, 18(6): 706
10Ihor B, Dawna D, Qais A. Effect of low and high-fat meals on Tacrolimus absorption following 5 mg single oral doses to healthy human subjects [J]. J Clin Pharmacol, 2001,41:176
